Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Seeds Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 90
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 70
Rounds per year 2.90
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.22
Key employees 2
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • Software
  • Biotechnology
  • Artificial Intelligence
  • Information Technology
Summary

The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2019. Considering the real fund results, this VC is 11 percentage points more often commits exit comparing to other organizations. Deals in the range of 5 - 10 millions dollars are the general things for fund.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Seeds Capital, startups are often financed by Openspace Ventures, Jungle Ventures, Wavemaker Partners. The meaningful sponsors for the fund in investment in the same round are Jungle Ventures, Wavemaker Partners, Heritas Capital Management. In the next rounds fund is usually obtained by RNT Associates, Mitsui & Co, Jungle Ventures.

The overall number of key employees were 2.

Among the most popular portfolio startups of the fund, we may highlight Cialfo, Neuron Mobility, One BioMed. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Automotive, Health Care.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Seeds Capital:
Typical Co-investors
Seeds Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Seeds Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Singapore
Funds with similar focus located in Singapore:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Qritive

Artificial Intelligence
Biotechnology
Health Care
Information Technology
Software
$7M09 Jan 2023 Singapore, Central, Singapore

AlterPacks

Biotechnology
Packaging Services
Recycling
Waste Management
$1M03 Jan 2023 Singapore, Central Region, Singapore

Alchemy Foodtech

Biotechnology
Food and Beverage
Health Care
$3M22 Dec 2022 Singapore, Central, Singapore

Aktivolabs

Fitness
Health Care
Lifestyle
$10M14 Dec 2022 Singapore, Central, Singapore

KYAN Therapeutics

Artificial Intelligence
Biopharma
Biotechnology
Health Care
Life Science
Pharmaceutical
Therapeutics
$5M26 Oct 2022 Singapore, Central Region, Singapore

Oncoshot

Clinical Trials
Electronic Health Record (EHR)
Health Care
Health Diagnostics
Information Technology
Medical
Online Portals
$900K13 Oct 2022 Singapore, Central Region, Singapore

Structo

Cloud Computing
Developer APIs
Web Development
Web Hosting
$10M06 Oct 2022 Singapore, Central, Singapore

Nutrition Technologies

Agriculture
AgTech
Animal Feed
Biotechnology
Farming
Sustainability
Waste Management
$20M12 Sep 2022 Singapore, Central, Singapore

MiyaHealth

Health Care
Medical
17 Aug 2022 Singapore, Central Region, Singapore
News
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies

– Nuevocor has announced the completion of an oversubscribed $24m Series A financing round.
– The round was co-led by EVX Ventures and Boehringer Ingelheim Venture Fund (BIVF), with EDBI, Xora Innovation, SEEDS Capital and other investors joining the syndicate.
– Funds will be used to accelerate the preclinical development of its lead programme, an adeno-associated virus (AAV) – based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the lamin A/C (LMNA) gene.

Zenyum Receives $40M Series B Funding

– Zenyum, a Singapore based direct-to-consumer dental products brand, raised $40m in Series B funding.
– The round was led by L Catterton, which invested invested $25m, with participation from existing investors Sequoia Capital India, RTP Global, Partech, TNB Aura, Seeds Capital, and FEBE Ventures.
– In conjunction with the funding, Anjana Sasidharan, Head of Growth Investments for L Catterton Asia, will be joining Zenyum’s board.
– The company intends to use the funds to accelerate expansion across Asia, deepen its range of products, and further develop its technology stack.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Seeds Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: